G protein signaling in the parasite Entamoeba histolytica by Bosch, Dustin E & Siderovski, David P
REVIEW
G protein signaling in the parasite Entamoeba
histolytica
Dustin E Bosch1 and David P Siderovski2
The parasite Entamoeba histolytica causes amebic colitis and systemic amebiasis. Among the known amebic factors
contributing to pathogenesis are signaling pathways involving heterotrimeric and Ras superfamily G proteins. Here, we review
the current knowledge of the roles of heterotrimeric G protein subunits, Ras, Rho and Rab GTPase families in E. histolytica
pathogenesis, as well as of their downstream signaling effectors and nucleotide cycle regulators. Heterotrimeric G protein
signaling likely modulates amebic motility and attachment to and killing of host cells, in part through activation of an
RGS-RhoGEF (regulator of G protein signaling–Rho guanine nucleotide exchange factor) effector. Rho family GTPases, as well
as RhoGEFs and Rho effectors (formins and p21-activated kinases) regulate the dynamic actin cytoskeleton of E. histolytica
and associated pathogenesis-related cellular processes, such as migration, invasion, phagocytosis and evasion of the host
immune response by surface receptor capping. A remarkably large family of 91 Rab GTPases has multiple roles in a complex
amebic vesicular trafficking system required for phagocytosis and pinocytosis and secretion of known virulence factors, such
as amebapores and cysteine proteases. Although much remains to be discovered, recent studies of G protein signaling in
E. histolytica have enhanced our understanding of parasitic pathogenesis and have also highlighted possible targets for
pharmacological manipulation.
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ENTAMOEBA HISTOLYTICA CAUSES AMEBIC COLITIS
AND SYSTEMIC AMEBIASIS
Epidemiology, disease sequelae and current treatment
options
The parasite E. histolytica is the causative agent of infectious
amebic colitis and systemic amebiasis.1 The worldwide
prevalence of E. histolytica infection is not precisely known,
with the most recent published estimates2 being approximately
50 million infections and 100 000 deaths annually.
Epidemiological estimates have been historically complicated
by limitations of diagnostic tests, as well as difficulty in
differentiating E. histolytica from the morphologically similar
but typically non-pathogenic related Entamoeba species,
E. dispar and E. moshkovskii.3 However, more recently
developed antigen detection and PCR-based modalities with
improved sensitivity and specificity have allowed more
accurate regional estimations of E. histolytica infections.4,5
The prevalence of E. histolytica infection is particularly high
among susceptible populations with limited access to clean
water. For instance, a study of preschool-aged children in
Bangladesh revealed annual infections in 40–50% of subjects,6
a profile of Orang Asli ethnic groups in Malaysia found an
overall prevalence of E. histolytica-positive stool samples to be
15–20%,7 and E. histolytica was detected by PCR in 10–15% of
a rural Mexican population.8 The prevalence of antibodies
specific for E. histolytica in sera of a Chinese population varied
from 0.5 to 14%, depending on geographical location.9 An
inter-relationship between host nutritional status and
susceptibility to E. histolytica infection has also recently
begun to emerge (reviewed in Verkerke et al.10). Although
E. histolytica infection is relatively rare in developed countries,
such as the United States, it does occur among travelers,
immigrants and select susceptible subpopulations.11,12
Furthermore, outbreaks of E. histolytica have occurred due
to contaminated municipal water supplies (for example,
Barwick et al.13).
The life cycle of E. histolytica consists of an interchange
between an encysted form and a motile, pathogenic,
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trophozoite form. E. histolytica cysts, shed in the feces of
infected human hosts, are transmitted primarily by ingestion
of contaminated water or food.1 Excystation occurs in the
small intestine, and the resultant E. histolytica trophozoites
may then colonize the large intestine while evading the host
immune response.3 Although the majority of E. histolytica
infections are asymptomatic, trophozoites can penetrate the
intestinal mucous barrier, resulting in colitis.1 Amebic colitis is
characterized by trophozoite-mediated killing of intestinal
epithelial cells and responding immune cells, as well as local
tissue destruction.14 In rare cases, E. histolytica trophozoites
can enter the blood stream and spread systemically, giving rise
to abscesses, primarily in the liver and less frequently in the
lungs and brain.3 Although systemic amebiasis requires
previous intestinal infection, amebic liver abscesses can
develop in the absence of symptomatic colitis14,15 and are
known to appear months or years following exposure.16 Thus,
treatment is recommended for patients with E. histolytica
infection, even in the absence of symptomatic disease.3
Nitroimidazoles, such as metronidazole, are the current best
drugs for the treatment of invasive amebiasis.3 Approximately
90% of patients with mild or moderate amebic colitis
respond to nitroimidazole therapy, although persistent
intestinal infection often requires additional treatment with
paromomycin or diloxanide furoate for complete eradication.3
However, a significant fraction of patients with E. histolytica
infection do not respond to nitroimidazoles, and relatively rare
side effects such as allergic reactions, neuropathies and
additional gastrointestinal symptoms can also affect
treatment tolerance.17 Resistance of E. histolytica infection to
nitroimidazoles and paromomycin has not yet emerged as a
major limitation to treatment; however, numerous examples of
antibiotic resistance in other microorganisms warrants further
exploration of alternative pharmacological therapeutics.18
A recent study identified auranofin, an FDA (Food and
Drug Administration)-approved rheumatoid arthritis drug,
as a potent inhibitor of E. histolytica thioredoxin reductase
and further demonstrated its protective effects in a mouse
model of amebic colitis.19 Other classes of compounds have
also recently been pursued as nanomolar-potency inhibitors of
E. histolytica growth in culture.20,21 Despite existing effective
therapies, E. histolytica infection and associated disease
remains endemic in many parts of the world, particularly in
areas with contaminated drinking water and food sources.6,8
Problems with sanitation implementation and access to
appropriate therapeutics could potentially be circumvented
by the development of an E. histolytica vaccine, and efforts
toward this goal are ongoing (for example, Abd Alla et al.22).
Parasite factors in pathogenesis
A number of E. histolytica molecular components have been
thoroughly established as contributors to its pathogenesis.
During initial intestinal colonization, E. histolytica adheres to
the colonic mucin layer primarily through a galactose-
inhibitable lectin, known as the Gal/GalNAc lectin (reviewed
in Petri et al.23). The trimeric surface protein is also a
dominant factor in parasite attachment to host cells and
subsequent tissue destruction and functions interdependently
with the dynamic actin cytoskeleton of E. histolytica.23
Trophozoites also secrete pore-forming peptides known as
‘amebapores’ that assemble within host cell membranes
to trigger cell death (reviewed in Leippe and Herbst24).
A relatively large family of E. histolytica-encoded cysteine
proteases also contributes to host cell killing, as well as
degradation of the host extracellular matrix during invasive
amebic infection and evasion of the host immune response
through proteolysis of immunoglobulins and complement
(reviewed in Que and Reed25). Many regulators of the actin-
rich cytoskeleton within E. histolytica are also emerging as
contributors to pathogenesis-related processes, such as
phagocytosis of host cells, trophozoite motility and tissue
invasion, and shedding of host antibodies by surface receptor
capping (reviewed in Voight and Guillen,26 Tavares et al.,27
Meza et al.28 and Labruyere and Guillen29).
HETEROTRIMERIC G PROTEINS AND RAS
SUPERFAMILY GTPASES
Sequencing of the complete E. histolytica genome30 and
genome-wide expression studies (for example, Gilchrist
et al.31) have revealed large numbers of putative cell
signaling molecules expressed in this single-celled parasite,
including a substantial family of 4300 kinases.32 Also
prominent within the E. histolytica genome are genes
encoding heterotrimeric G protein subunits (Ga, Gb and
Gg) and a large number of small, B21 kDa G proteins
belonging to the Ras superfamily.30 Ga subunits and Ras
GTPases are molecular switches and cellular signaling nodes
that bind guanine nucleotides (guanosine triphosphate (GTP)
or guanosine diphosphate (GDP)) through highly conserved,
nucleotide-interacting sequencing motifs.33,34 As mammalian
G proteins are known to be master regulators of
cellular functions spanning cell division and proliferation,
cytoskeletal dynamics, vesicular trafficking and specific
responses to extracellular cues,33,35 it is likely that
E. histolytica homologs are similarly important for
trophozoite biology and pathogenicity. G protein signaling
pathways are also notable for their amenability to
pharmacological manipulation; particularly, heterotrimeric G
protein signaling via G protein-coupled receptors (GPCRs) is
the target of approximately one-third of all currently FDA-
approved drugs.36,37
REGULATION OF THE GUANINE NUCLEOTIDE CYCLE
Heterotrimeric G proteins
A Ga subunit in its inactive, GDP-bound state forms a
heterotrimer with the obligate Gbg dimer (Figure 1).
A seven-transmembrane domain GPCR, when activated by
an extracellular ligand, engages the heterotrimer and catalyzes
the release of GDP by the Ga subunit.38 Thus the GPCR is a
guanine nucleotide exchange factor (GEF) for the Ga subunit,
promoting GDP release and subsequent binding of GTP, which
is present in a higher concentration than GDP in the
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cytoplasm.34 Nucleotide exchange is accompanied by
structural rearrangement of three switch regions in the
Ras-like domain of the Ga subunit, resulting primarily from
nucleotide-binding pocket interactions with the g-phosphoryl
group of GTP.39 The activated Ga GTP separates from the
Gbg dimer, and both components are free to signal through
various downstream effectors.34 Mammalian Ga subtypes
engage different effectors: Gas activates, while Gai/o inhibits,
cyclic AMP (cAMP) generation by adenylyl cyclase; Gaq
stimulates phospholipase-Cb activity and subsequent release
of intracellular calcium stores; and Ga12/13 signaling leads to
Rho GTPase activation through RhoGEFs.34,40 Signaling is
terminated by the intrinsic GTPase activity of the Ga subunit,
leading to release of free phosphate and repeated formation
of the Ga GDP/bg heterotrimer (Figure 1). Ga subunit-
mediated GTP hydrolysis, and thus signal termination, is
accelerated by a family of GTPase-accelerating proteins (GAPs)
known as ‘regulators of G protein signaling’ (RGS proteins).41
RGS proteins do not directly contribute to the GTP hydrolysis
reaction, but instead stabilize the Ga switch regions to allow
for efficient hydrolysis.42 Some Ga subunit effectors also
enhance GTPase activity; particularly, phospholipase-Cb
serves as a GAP for Gaq, and the Ga12/13 subfamily RGS-
RhoGEF effectors possess a GTPase-accelerating domain (the
rgRGS domain) with distant homology to RGS proteins.40,43
An additional class of Ga regulators is the GoLoco motif
protein family, members of which serve as guanine nucleotide
dissociation inhibitors (GDIs) by binding directly to Ga GDP
and preventing nucleotide release.44
Ras superfamily GTPases
The nucleotide cycle of Ras superfamily G proteins closely
parallels that of heterotrimeric G proteins. Inactive, GDP-
bound Ras GTPases are activated by guanine nucleotide
exchange factors (GEFs) in a process that involves structural
rearrangement of two switch regions within the G protein to
promote release of GDP and the Mg2þ cofactor
(Figure 1).33,45 Following binding of GTP, activated Ras
superfamily GTPases engage a host of different downstream
effectors. In contrast to heterotrimeric G proteins, the intrinsic
GTPase activity of Ras superfamily members is typically very
slow. Thus, Ras superfamily-specific GAPs truly ‘activate’ GTP
hydrolysis (rather than merely accelerate hydrolysis as is the
case with Ga GAPs) by contributing directly to the reaction, as
typified by the ‘arginine finger’ of p120GAP.46,47 In another
distinct difference with Ga subunits, Ras superfamily GTPases
typically possess a C-terminal cysteine residue that is
isoprenylated in cells by specific lipid moiety transferases, a
post-translational modification that promotes their membrane
association.33 GDIs associated with Ras superfamily GTPases
slow nucleotide exchange and employ an isoprenyl
group-binding site to extract GTPases from, and shuttle
them between, cellular membranes.48,49
HETEROTRIMERIC G PROTEIN SIGNALING IN
E. HISTOLYTICA
Before completion of the E. histolytica genome sequencing
project,30 indirect evidence for heterotrimeric G protein
signaling components existing within E. histolytica
accumulated in the literature, but specific genes and
associated protein products had not been identified. Studies
on the effects of histamine and serotonin, typical GPCR
agonists, on E. histolytica trophozoites revealed alterations in
pathogenicity and phagocytic activity, as well as enhancement
of virulence in a mouse model,50–53 suggesting the possible
presence of a hormone-sensing G protein signaling pathway
within E. histolytica. Exposure of E. histolytica to fibronectin
fragments was seen to result in actin cytoskeleton
rearrangements, as well as changes in intracellular calcium
and cAMP levels,54–56 raising the possibility of fibronectin-
responsive Gaq, Gas and/or Gai/o signaling within
trophozoites. Additional indirect evidence arose from studies
utilizing cholera toxin (CTX) and pertussis toxin (PTX),
factors known to adenosine diphosphate (ADP)-ribosylate
and activate Gas or inhibit Gai/o signaling, respectively.57
Both CTX and PTX were reported to ADP-ribosylate
Figure 1 Nucleotide cycle regulation of heterotrimeric and Ras
superfamily G proteins. (a) Ga subunits cycle between guanosine
diphosphate (GDP)- and guanosine triphosphate (GTP)-bound
states. G protein-coupled receptors (GPCRs) serve as guanine
nucleotide exchange factors (GEFs) for G protein heterotrimers,
stimulating their release of GDP. Conversely, GoLoco motifs are
guanine nucleotide dissociation inhibitors (GDIs) that slow
nucleotide exchange by Ga subunits. RGS proteins are GTPase-
accelerating proteins (GAPs) for Ga subunits, promoting signal
termination by both activated Ga subunits and free Gbg. (b) The
small G protein nucleotide cycle parallels that of heterotrimeric G
proteins, with GEF-stimulated and GDI-inhibited nucleotide
exchange as well as GAP-mediated activation of GTP hydrolysis.
RGS, regulators of G protein signaling.
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multiple proteins of diverse molecular weights in trophozoite
lysates, and toxin treatment led to increased cAMP formation
in both cytoplasmic and cell membrane preparations, as
well as increased adhesion to a fibronectin-coated surface.58
Studies in the related species Entamoeba invadens further
suggested the possibility of heterotrimeric G protein
signaling in Entamoeba. The catecholamines epinephrine and
norepinephrine, classical GPCR agonists in mammals, were
found to promote E. invadens encystation at high-nanomolar
to low-micromolar concentrations, although a traditional
concentration–response pattern was not observed.59 The
authors hypothesized the presence of a b1 adrenergic
receptor-like molecular entity on trophozoite cell surfaces, as
further supported by radioligand binding with a specific
antagonist. Furthermore, chromatography techniques
identified catecholamines within E. histolytica extracts,
suggesting a potential autocrine G protein signaling loop.59
Additional studies implied that CTX or PTX treatment, as well
as the adenylyl cyclase-stimulating compound forskolin, could
also promote cAMP accumulation in (and encystation of)
E. invadens, while application of an adenylyl cyclase inhibitor
was reported to have opposite effects.60 Together with
epinephrine-induced binding of GTPgS on trophozoite
membranes, these findings were suggestive of an adrenergic
receptor signal transduction cascade within Entamoeba
involving Gas- and/or Gai/o-like proteins, with opposing
regulatory effects on an adenylyl cyclase.
However, the sequenced E. histolytica genome,30 as well as
those of E. dispar and E. invadens, have revealed only the
presence of two putative Ga subunits, a single Gb subunit
and at least two Gg subunits.61,62 Absent from the genome are
clear homologs to mammalian phospholipase-Cb as well
as G protein-regulated adenylyl cyclases or cyclic nucleotide
phosphodiesterases.30 Thus, although exposure of E. histolytica
to stimuli such as fibronectin and catecholamines may result
in cAMP accumulation or increased intracellular calcium
levels, it is unlikely that these observed effects are mediated
by traditional Gas/adenylyl cyclase, Gai/o/adenylyl cyclase or
Gaq/phospholipase-Cb signaling pathways. Also, we have been
unable to identify within the E. histolytica genome any genes
encoding clear homologs of adrenergic, histamine or serotonin
GPCRs (unpublished data and Bosch et al.61), suggesting that
the functional effects of these biogenic amines on trophozoites
may not be mediated by traditional GPCR/heterotrimeric
G protein signal transduction.
Analysis of both the sequence and structure of the
Ga subunit EhGa1 revealed a lack of homology to mammalian
Ga subfamilies, including Gas and Gai/o.61 This finding,
together with a lack of the C-terminal cysteine required for
ADP ribosylation by PTX, suggests that EhGa1 is unlikely to
be specifically modified by bacterial toxins.61 The observed
effects of CTX and PTX treatment on Entamoeba trophozoites
might instead result from off-target effects, a hypothesis
supported by CTX- and PTX-mediated ADP ribosylation of
multiple proteins of diverse molecular weights in E. histolytica
trophozoite lysates.58 Despite its lack of phylogenetic
relationship to any particular mammalian Ga subfamily,61
EhGa1 shares functional similarity with mammalian Ga12/13
subunits in engaging and contributing to the activation of an
RGS-RhoGEF effector (Figure 2).63 An evolutionary origin of
E. histolytica heterotrimeric G protein signaling independent
from, but functionally convergent with, that of mammalian
Ga12/13/RGS-RhoGEF pathways is suggested by multiple
factors, including the sequence and structural divergence
of EhGa1, the canonical nature of its interaction with
the EhRGS-RhoGEF RGS domain (that is, as opposed to the
rgRGS domain found in mammalian RhoGEFs), and the
structural features of the autoinhibited EhRGS-RhoGEF.61,63
Expression of constitutively active EhGa1 and EhRacC
mutants, together with the effector EhRGS-RhoGEF, leads to
Rho family GTPase activation in Drosophila S2 cells,63
suggesting that heterotrimeric G protein and Rho family
GTPase signaling pathways communicate in E. histolytica
(Figure 2). However, no specific Rho family GTPase has yet
been identified as an EhRGS-RhoGEF substrate. Overexpres-
sion of either wild-type EhGa1 or a dominant-negative,
constitutively EhGbg-bound EhGa1 mutant has opposing
effects on trophozoite migration, invasion, and host cell
attachment and killing, suggesting that heterotrimeric G
protein signaling modulates multiple pathogenesis-related
behaviors.61 Perturbation of EhGa1 expression also leads to
significant changes in the E. histolytica transcriptome and
alters the secretion of cytotoxic cysteine proteases,61 suggesting
a possible functional overlap with Rab family GTPases
(see below). Overexpression of EhRGS-RhoGEF has similar
Figure 2 Model of heterotrimeric G protein signaling in
E. histolytica. Activated EhGa1, together with guanosine
triphosphate (GTP)-bound EhRacC, engages the autoinhibited
EhRGS-RhoGEF (E. histolytica regulator of G protein signaling–Rho
guanine nucleotide exchange factor) to promote Rac GTPase in
Drosophila S2 cells,63 although no specific E. histolytica Rho
family substrate for EhRGS-RhoGEF has yet been identified. Both
EhGa1 and EhRGS-RhoGEF alter trophozoite migration, host cell
attachment and cell killing by altered cysteine protease
secretion.61,63 An associated G protein-coupled receptor (GPCR) is
postulated but not yet established within this signaling pathway;
Despite its name, the protein EhGPCR-1 is more likely a Wnt-
binding factor than a ligand-activated heterotrimeric G protein
GEF.61 DH, Dbl homology; GDP, guanosine diphosphate; PH,
pleckstrin homology.
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effects on trophozoite function when compared with
overexpression of dominant-negative EhGa1, consistent
with the function of EhRGS-RhoGEF as a EhGa1 GAP
(also demonstrated in vitro) and, thus, a negative regulator
of heterotrimeric G protein signaling in the context of its
overexpression.61,63 Nucleotide exchange is rate-limiting in the
EhGa1 nucleotide cycle,61 as seen with mammalian Ga
subunits, suggesting that GEF activity is needed for signal
activation. Yet the E. histolytica genome lacks homologs of
non-receptor GEFs for heterotrimeric G proteins such as Ric-8
and GIV,30,64 leading to the hypothesis that E. histolytica may
express one or more GPCRs (that is, a putative cell surface-
spanning, EhGa1-directed GEF; Figure 2). Although a bona
fide heterotrimeric GPCR has not yet been identified in this
organism, one or more receptor/ligand pairs would provide
valuable tools for manipulating G protein signal transduction
in E. histolytica and also potentially serve as a candidate drug-
discovery target.36,61
A second, putative Ga subunit (AmoebaDB acc. no.
EHI_186910) exhibits a unique domain structure, with an
N-terminal Ga-like fold easily identifiable despite substantial
sequence divergence from mammalian Ga subunits and a
C-terminal PP2C-related phosphatase domain.62 The Ga-like
region of this protein also lacks determinants for CTX- or
PTX-mediated ribosylation (as does EhGa1); furthermore, this
putative Ga subunit also lacks the otherwise very well-
conserved nucleotide-binding motifs shared among all G
proteins, suggesting a lack of nucleotide binding by this
protein (unpublished data and Wittinghofer and Vetter65).
This apparently expressed protein awaits functional assessment
of its Ga-like domain and its unique relationship to the
adjacent phosphatase domain.
EhGb1 dimerizes with one of two E. histolytica Gg subunits
when expressed in mammalian cells, and the EhGbg dimer in
turn binds EhGa1 in a nucleotide state-selective fashion.61
Gbg subunits also frequently engage downstream effectors,
even when the associated Ga subunits lack a major
known effector, as seen in the cases of Arabidopsis
thaliana sugar-sensing and yeast pheromone signaling.66,67
Signaling downstream of EhGbg is a distinct possibility for
E. histolytica and may contribute to the phenotypic effects of
perturbed EhGa1 expression;61 however, no EhGbg effectors
have yet been identified.
RAS SUPERFAMILY GTPASES IN E. HISTOLYTICA
The E. histolytica genome encodes a remarkably large number
of small GTPases for a single-celled parasite (4170 annotated
in AmoebaDB68), suggesting a prominent role for Ras
superfamily G protein signaling. The Ras superfamily can be
divided into the Ras subfamily, typically regulating cell
proliferation and survival; the Rho family that regulates actin
organization, the cell cycle and gene expression; the Ran
family, implicated primarily in nucleocytoplasmic transport;
and the Rab and Arf families, known as regulators of vesicular
transport and trafficking (reviewed in Wennerberg et al.33).
Ten Ras proteins and two related Rap homologs have been
described in E. histolytica,69,70 although the complete Ras
subfamily has not been enumerated since completion of the
E. histolytica genome sequencing project. At least 20 Rho
family GTPases, including Rho, Rac and Cdc42 homologs, are
transcribed by E. histolytica trophozoites.71–73 The Rab family
is the most numerous small G protein group described in
E. histolytica, with 91 annotated genes.74 Although not yet
described in the literature, putative Ran and Arf family
GTPases also exist in the E. histolytica genome.68 Although a
small fraction of E. histolytica Ras superfamily GTPases has
been investigated, the extent of functional redundancy,
signaling specificity and nucleotide cycle regulation among
these small G proteins remain largely unknown. Given the
poor genetic tractability of E. histolytica trophozoites,
investigations of G protein signaling in this organism
have largely been limited to overexpression studies. Although
overexpression is certainly an informative genetic pertur-
bation, it should be noted that overexpressed G proteins, or
nucleotide cycle-impaired mutants thereof, are subject to
potential mislocalization and non-physiological functions.
Ras family GTPases
An initial study in E. histolytica trophozoites identified two Ras
genes and two related Rap genes, as well as a single protein that
apparently cross-reacted with a mammalian anti-Ras anti-
body.69 Ras family GTPases in mammals and yeast are
isoprenylated with either a geranylgeranyl or a farnesyl group
at the characteristic C-terminal CaaX motif, where ‘a’ is an
aliphatic amino acid, and the final residue is predictive of
either geranylgeranylation or farnesylation.33 Expression
of EhRap2, EhRas1 and CaaX motif mutants thereof in
mammalian reticulocytes revealed that E. histolytica Ras
GTPases can be isoprenylated, but that their CaaX motif
sequences are less predictive of the specific isoprenyl group
added than mammalian counterparts.75 An E. histolytica
farnesyltransferase, consisting of two subunits, was later
cloned and shown to farnesylate human H-Ras and
EhRas4 to the exclusion of three other E. histolytica
Ras isoforms, indicating a distinct CaaX motif selectivity
for isoprenylation.70 Recombinant E. histolytica farnesyl
transferase is resistant to mammalian farnesyltransferase
inhibitors, precluding their use as tools in studying Ras
GTPase function in E. histolytica trophozoites. Ras GTPases
and related signaling machinery have been the targets of much
pharmaceutical development effort, given the centrality of
oncogenic Ras signaling to cellular proliferation and survival in
many human malignancies.76 However, no studies of
perturbed Ras signaling in E. histolytica have yet emerged.
Similarly, putative regulators of Ras nucleotide cycling (for
example, GEFs and GAPs) and candidate Ras effectors are
currently understudied in E. histolytica.
Rho family GTPases
E. histolytica possesses a highly dynamic, actin-rich
cystoskeleton that participates in many pathogenesis-related
processes (reviewed in Meza et al.28), as well as two major
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actin-associated myosins (reviewed in Labruyere and Guillen29
and Marion et al.77). Remarkably rapid actin remodeling is
apparent in trophozoite motility,78 a process regulated by
extracellular matrix interactions79 as well as self-generated
chemokines.80 Cytoskeletal remodeling is also intimately
associated with E. histolytica phagocytosis26 and surface
receptor capping.27 As master regulators of the actin
cytoskeleton, as well as cell division and transcription in
mammals, Rho GTPases and their associated proteins have
been a focus of intense investigation in E. histolytica.
The first identified Rho family GTPase in E. histolytica was
EhRho1 (Figure 3a), also later referred to as EhRhoA1.71 As a
homolog of human RhoA, EhRho1 was a natural candidate
substrate for the Rho-inhibiting C3 exoenzyme from
Clostridum botulinum, a protein whose ectopic expression in
E. histolytica trophozoites leads to ribosylation of an B25-kDa
protein and reduces both proliferation and host cell killing.81
However, recombinant EhRho1 was later found not to be a
substrate for C3 exoenzyme,82 but instead glucosylated in vitro
by Clostridum difficile toxin B and Clostridum novyi a-toxin.83
However, use of these two Clostridium toxins to study EhRho1
function in vivo is impaired by a lack of trophozoite
membrane permeability.83 A structural study of EhRho1 has
more recently highlighted its conserved conformational
difference between GDP- and GTP-bound states, as well as
its distinct lack of a ‘Rho insert helix’—a structural feature
that differentiates all other Rho family GTPases from the
greater Ras superfamily.73 EhRho1 also differs from its
mammalian homologs at a key nucleotide-binding residue, a
feature found to confer rapid intrinsic nucleotide exchange but
not constitutive activity.73,82 However, EhRho1 does exhibit a
signature activity of other Rho family GTPases; expression of a
constitutively active mutant in human cells promotes actin
stress fiber formation.73 Activated EhRho1 GTP binds a
Diaphanous-related formin effector protein, EhFormin1, to
the exclusion of other E. histolytica Rho family
GTPases (Figure 3a).73,84 EhFormin1 is known to modulate
actin polymerization, to be autoinhibited by an N- to
C-terminal intramolecular interaction like its well-studied
mammalian homologs,85 and to be specifically activated
by EhRho1 GTP.84 A recent crystal structure of the
EhRho1 GTPgS/EhFormin1 complex revealed a similar
mode of intermolecular interaction as compared with
mammalian counterparts, with the exception of a missing
secondary binding site involving the Rho insert helix, and
further yielded insights into specificity requirements for Rho
GTPase/effector pairings.84 EhFormin1 (also called EhDia)
belongs to a family of eight E. histolytica formin proteins,
three of which are Diaphanous-related (that is, containing
tandem Rho GTPase-binding domains (GBDs) and
formin homology 3 domains (FH3s)).86,87 Overexpressed
EhFormin1 in trophozoites localizes to pseudopodia, the
microtubular assembly in the nucleus, and cytoplasmic
F-actin structures in response to serum.87 Furthermore,
EhFormin1- and EhFormin2-overexpressing ameba exhibit
cell division defects, with an increased number of nuclei per
cell and increased average DNA content per nucleus,87
suggesting that EhRho1/EhFormin1 signaling may be
involved in actin polymerization in pseudopodia and/or
trophozoite cell division (Figure 3a).
EhRho1 has also been implicated in signaling downstream
of lysophosphatidic acid, an agent that promotes actin poly-
merization and associated F-actin structures, alters concana-
valin A (ConA)-induced surface receptor capping, increases
migration and invasion and modulates erythrophagocytosis
by E. histolytica trophozoites.54,88 Lysophosphatidic acid
treatment (of the order of 10mM concentration) has been
reported to promote EhRho1 activation within E. histolytica, as
measured by a GST (glutathione S-transferase)-Rhotekin Rho-
binding domain pull-down assay.54,88 However, we and others
have been unable to observe nucleotide-specific interaction
Figure 3 EhRho1 and EhRacA signaling modulate pathogenic
behaviors in E. histolytica. (a) Nucleotide exchange on EhRho1 is
known to be catalyzed by E. histolytica guanine nucleotide
exchange factor 1 (EhGEF1) in vitro.98 EhRho1 engages the
GTPase-binding domain–formin homology 3 (GBD-FH3) domain
tandem of the diaphanous-related and autoinhibited EhFormin1
to modulate actin polymerization.84 EhFormin1 has also been
implicated in trophozoite proliferation and cytokinesis.87
(b) EhRacA nucleotide exchange is known to be accelerated by
EhGEF3 in vitro.102 Constitutively active EhRacA perturbs
phagocytosis and chemotaxis, as well as surface receptor capping
in trophozoites.89 EhRacA  guanosine triphosphate (GTP) was also
shown to bind E. histolytica p21-activated kinase 2 (EhPAK2), a
likely effector whose kinase domain is implicated in collagen
matrix invasion, cytokinesis and surface receptor capping.90
Stimulation of EhPAK2 kinase activity by EhRacA is postulated but
has not yet been established. DH, Dbl homology; GDP, guanosine
diphosphate; PH, pleckstrin homology.
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between GST-Rhotekin Rho-binding domain and either
epitope-tagged EhRho1 expressed in cells or purified
recombinant EhRho1 (unpublished data), suggesting that
EhRho1 binding observed in other studies54,88 may be the
result of non-specific interactions, or that the employed
anti-EhRho1 antibody may cross-react with one or more
other E. histolytica Rho family GTPases. Lysophosphatidic
acid-induced EhRho1 activation has also been assessed by
co-immunoprecipitation with a human antigen-derived
anti-Rho kinase 2 antibody;54 however no Rho kinase
2 homologs in E. histolytica have yet been described or are
apparent in the genome.68
A number of Rac GTPase homologs are also expressed in
E. histolytica,72 including EhRacA. Overexpression of a
constitutively active EhRacA(G12V) in trophozoites leads
to delayed cell division, as well as defects in phagocytosis
of bacteria, human erythrocytes and mucin-coated beads
and alterations in ConA-stimulated receptor capping.89
Furthermore, EhRacA was seen to specifically engage the
p21-binding domain of the p21-activated kinase (PAK)
EhPAK2, both in amebic lysates and in the context of
purified recombinant proteins (Figure 3b).90 PAKs are
effectors for canonical Rho family GTPases, and their serine/
threonine kinase activities and/or localizations are modulated
by the binding of activated G proteins (reviewed in Kumar
et al.91). Trophozoites engineered to overexpress the kinase
domain of EhPAK2, but not the full-length protein or the
N-terminal regulatory region, exhibit defects in collagen
matrix invasion, surface receptor capping and cytokinesis.90
Phenotypic overlap between EhRacA(G12V) and EhPAK2
kinase domain strains suggests a role for EhRacA/EhPAK2
signaling in surface receptor capping and regulation of
cell division.
EhRacG has also been identified as a contributor to
pathogenesis-related functions in E. histolytica. Overexpression
of constitutively active EhRacG(G12V) in trophozoites leads to
formation of a minor population of giant multinucleated
cells, indicating a likely cytokinesis defect.92 Filamentous actin
arrangements and surface receptor capping are also altered
with EhRacG(G12V) expression, and electron microscopy
observations suggest increased budding of membrane
vesicles.92 Endogenously expressed EhRacG is enriched in
ConA-induced uroids, together with filamentous actin and
myosin II, consistent with its regulatory role in surface
receptor capping via modulation of the actin cytoskeleton.92
Activated EhRacC was recently shown to directly engage
the heterotrimeric G protein effector EhRGS-RhoGEF.63
Expression of constitutively active EhRacC, together with
constitutively active EhGa1 is required to achieve EhRGS-
RhoGEF activation in Drosophila S2 cells,63 suggesting a
convergence with heterotrimeric G protein signaling
(Figure 2). However, the contributions of EhRacC to cellular
processes in E. histolytica remain to be directly assessed.
A number of other putative Rho family GTPase effectors
have been described in E. histolytica, although without
unequivocally associated G proteins. For instance, two other
diaphanous-related formins with GBD-FH3 domain tandems
are encoded by the E. histolytica genome in addition to the
EhRho1 effector EhFormin1.87 Overexpressed EhFormin2 in
trophozoites, like EhFormin1, is localized in pseudopodia and
pinocytic and phagocytic vesicles, and results in mitosis and
cytokinesis defects,87 suggesting some functional redundancy
among diaphanous-related formins despite differences in their
Rho-GTPase binding sites and, thus, likely differences in
Rho activator specificities (Bosch et al.84 and unpublished
data). A fourth GBD-FH3 tandem protein, the actin-binding
EhNCABP166, has also been implicated as a modulator of
phagocytosis, chemotactic migration and possibly proliferation
in trophozoites.93 The small G protein specificity of
the EhNACAP166 GBD-FH3 domain tandem has been
investigated; however, these binding experiments were
conducted with denatured Rho GTPases,93 and intact Rho
tertiary structure is required for the typical Rho/GBD-FH3
association (for example, Bosch et al.84). Some of the seven
identified PAK family members, in addition to the EhRacA
effector EhPAK2, have also been studied in E. histolytica.
EhPAK (also called EhPAK1) localizes to pseudopods during
amebic migration and to the uroid upon ConA-induced
capping.94 The N-terminus of EhPAK1 was found to bind
human Rac1 with typical nucleotide specificity (that is,
dependent on the GTP-bound state) despite the lack of an
identifiable p21-binding domain; trophozoites overexpressing
the EhPAK1 kinase domain exhibit reduced migration, an
increased number of membrane extensions and an increased
rate of erythrocyte phagocytosis.95 EhPAK3 is also expressed in
trophozoites, and both recombinant EhPAK3 purified under
denaturing conditions and EhPAK3 immunoprecipitated from
amebic lysates exhibit apparent kinase activity.96
Putative regulators of Rho family GTPase nucleotide
cycling are also prominent in the E. histolytica genome,30
including B70 Dbl homology (DH) domain-containing
candidate RhoGEFs, B70 encoded RhoGAP domain-
containing proteins and a single RhoGDI (EhRhoGDI; for
example, Bosch et al.73). Although no studies of RhoGAP
proteins have yet emerged, they are likely to regulate
pathogenesis-related functions like their associated GTPases.
Recombinant purified EhRhoGDI binds EhRho1 in a
nucleotide state- and isoprenylation-dependent fashion.73 As
the only apparent RhoGDI, it is likely that this protein
also engages other inactive Rho GTPases in E. histolytica to
impair nucleotide exchange and regulate their subcellular
localization.
Better studied are a number of Dbl family RhoGEFs. For
example, overexpression of EhGEF1 in trophozoites decreases
total cellular filamentous actin, reduces amebic migration and
alters killing of mammalian cells.97,98 In vitro nucleotide
exchange assays indicate that EhGEF1 likely catalyzes
exchange on EhRacG and EhRho1 (the latter illustrated in
Figure 3a), although concentrations of GEF protein employed
in these assays as well as a concentration–response analysis
were not included in this report.98 Later studies have used
structural homology models to predict EhGEF1 DH domain
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point mutations that impair GEF activity toward EhRho1
and EhRacG, as indicated by maximal nucleotide analog
fluorescence at a single time point.99 However, kinetic
analysis is a preferable measure of GEF activity, as maximal
fluorescence readings are subject to artifacts due to differing
specific activities of recombinant proteins, non-specific
binding, fluctuations in instrumentation settings, and/or
‘buffer shifts’ in fluorescence that vary among protein
preparations. EhGEF1 small-molecule inhibitors have also
been pursued, based on a docking analysis using a homology
model to existing mammalian RhoGEF structures (B50% or
less sequence similarity).100 Five compounds were assessed for
EhGEF1 inhibition by in vitro nucleotide exchange assays and
found to be active at B50–100mM concentrations.100 However,
exchange kinetics were not assessed, a typical concentration–
response pattern was not obtained and direct binding of
compounds to EhGEF1 (or potentially Rho GTPases) has
not yet been demonstrated in these studies. Furthermore,
the specificity of these potential pharmacological tools, for
instance across other E. histolytica RhoGEFs, remains to be
determined.
The Armadillo-repeat containing EhGEF2 has been impli-
cated in erythrocyte phagocytosis, trophozoite proliferation
and chemotaxis, based upon an E. histolytica strain engineered
to overexpress a dominant-negative point mutant.101 Both the
N-terminal and DH domain regions were seen to contribute to
EhGEF2 membrane localization. EhGEF2 was also suggested to
activate EhRacA-D, EhRacG-H and EhCdc42 in vitro,101
although no kinetic analysis was provided in this report and
the fluorescence time courses shown appear to be caused by
buffer shifts upon GEF addition rather than a single
exponential binding event per se. Which Rho substrates and
dominant-negative mutant-impaired signals are relevant for
the observed in vivo effects are currently unknown.
The DH-PH (pleckstrin homology) domain tandem of a
third Dbl family RhoGEF, EhGEF3, stimulates nucleotide
exchange on EhRacA and EhRho1 in vitro.102 Simultaneous
EhGEF3 and EhRacA overexpression in E. histolytica leads
to increased migration toward fibronectin, whereas a
dominant-negative EhGEF3 mutant has the opposite effect.
Overexpressed EhGEF3, but not the dominant-negative point
mutant, also promotes EhRacA activation in trophozoites, as
assessed by a GST-EhPAK2 p21-binding domain pull-down
assay, suggesting a role for EhGEF3/EhRacA signaling in
chemotactic migration (Figure 3b).102 EhGEF3 and EhRacA
co-localize in caps induced by ConA treatment, suggesting a
possible additional role in surface receptor capping.102
Members of a family of 11 RhoGEFs in E. histolytica
each contain a FYVE domain, known to associate with
inositol phospholipids and to decorate early phagosomes in
trophozoites.103 A GFP-tagged mammalian FYVE domain
overexpressed in trophozoites was observed to translocate
to phagocytic cups and phagosomes during host cell
phagocytosis.104 One overexpressed FYVE domain-containing
RhoGEF, EhFP4, is also recruited to phagocytosis-related
structures,104 and overexpression of the isolated FYVE
domain from EhFP4 impairs trophozoite phagocytosis.
Interaction of EhFP4 or its DH-PH domains with
recombinant E. histolytica Rho family GTPases has been
assessed with pull-down assays. EhFP4 was seen to interact
with EhRacC, EhRacD, and two unnamed G proteins,
although nucleotide state selectivity was not assessed in this
study, and the authors reported inability to detect nucleotide
exchange activity.104 Thus, it remains to be established whether
these FYVE domain-containing RhoGEFs exhibit GEF activity
and whether there is any functional interplay between their
FYVE and DH-PH domains.
Rab family GTPases
The E. histolytica genome encodes a remarkable 91 Rab family
G proteins, many of which are not clear homologs
of mammalian Rabs, suggesting an unusually high degree of
complexity underlying vesicular trafficking regulation in
trophozoites.74,105,106 Endosomes isolated from E. histolytica
by magnetic fractionation are associated with virulence-
associated cysteine protease activity, as well as enrichment of
Rab GTPases, such as EhRab11 and potentially a Rab7
homolog.107 The importance of phagocytosis and pinocytosis
to nutrient uptake by trophozoites, the secretion of virulence
factors like amebapores and cysteine proteases, as well
as the critical role of membrane-associated proteins like the
Gal/GalNAc lectin to pathogenic behaviors, all support the
hypothesis that Rab-regulated vesicular trafficking is important
for E. histolytica biology and pathogenesis.14,23,24
EhRabA is localized to vesicles at steady state, but moves to
the leading edge in motile cells and the membrane opposite
ConA-induced caps, as well as to membrane extensions
upon N-formyl peptide-induced polarization.108 Expression
of a dominant-negative EhRabA mutant in trophozoites
produces changes in cell morphology and polarization,
impairs motility and reduces host cell attachment and
killing but has no observable effect on pinocytosis
or erythrophagocytosis.109 Conversely, overexpression of
constitutively active EhRabA perturbs erythrophagocytosis
and leads to formation of large tubular organelles apparently
derived from the endoplasmic reticulum (ER).110 Two
subunits of the Gal/Gal-NAc lectin and a cysteine protease
are mislocalized to these EhRabA-induced organelles, and
similar effects are seen with brefeldin-A treatment, suggesting
that EhRabA regulates trafficking between the ER and Golgi
apparatus in E. histolytica.110
EhRabB is one of the first identified and most frequently
studied Rab family GTPases in E. histolytica. Initial immuno-
fluorescence studies localized endogenous EhRabB to cyto-
plasmic vesicles and noted its translocation to the plasma
membrane and phagocytic cups during erythrophagocyto-
sis.111,112 Poor phagocytosis in a mutant E. histolytica strain
was seen to correlate with increased expression of EhRabB, as
well as substantial sequence differences between this mutant
EhRabB and wild-type EhRabB, providing further evidence for
its involvement in phagocytosis,113 although a causal
association was not established. EhRabB was also observed to
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be enriched at phagosomes in a proteomics study.114
Overexpression of wild-type EhRabB in trophozoites leads to
a small diminution of phagocytosis, while expression of a
dominant-negative mutant (N118I) leads to decreases in both
phagocytosis and cell monolayer destruction.115 Of particular
interest, EhRabB(N118I)-expressing trophozoites do not form
liver abscesses in a hamster model, while vector-transfected
and wild-type EhRabB-expressing amebae do form such
abscesses, establishing EhRabB signaling as likely important
for pathogenesis.115 EhRabB was reported to interact with
the transmembrane protein EhGPCR-1 by yeast two-hybrid,
although binding data were not shown in this study.116 Despite
its initial naming as a GPCR, further sequence analysis has
indicated that EhGPCR-1 is more likely a Wnt-binding factor
rather than a ligand-activated heterotrimeric G protein GEF
per se.61
E. histolytica also expresses Rab5- and Rab7-related G
proteins.117,118 Overexpressed EhRab5 and EhRab7A both
localize to independent vesicular structures at steady state,
but exposure of these overexpression-modified trophozoites to
erythrocytes is seen to cause convergence of the two Rabs
at a large ‘pre-phagosomal vacuole’, distinct from actual
phagosomes.119 Electron microscopic studies have identified
small amebapore-containing vesicles in the pre-phagosomal
vacuole, suggesting a role for EhRab5 and/or EhRab7A in
delivering cytotoxic amebapores to phagosomes.119 Consistent
with this hypothesis, overexpression of wild-type EhRab5
enhances phagocytosis kinetics and amebapore transport,
while expression of either constitutively active or dominant-
negative EhRab5 mutants impairs pre-phagosomal vacuole
formation and phagocytosis.119 EhRab7 also co-localizes
with early endosomes,117 and overexpression of EhRab7A in
trophozoites reveals its subcellular localization to lysosomes
and an increased acidic cellular compartment as well as
decreased cellular cysteine protease activity.120 A retromer-
like complex of E. histolytica proteins is seen to engage
recombinant EhRab7A in a nucleotide-dependent fashion,
primarily through the C-terminus of EhVps26, leading to
the hypothesis that EhRab7A may contribute to retrograde
transport from vacuoles and phagosomes to the Golgi
apparatus.120 An E. histolytica homolog of Rab8 has also
been cloned, but no cellular functions have yet been
established for this G protein other than its vesicular
localization.121,122
EhRab11 exhibits a punctate distribution in trophozoites
and moves to the cell periphery upon iron and serum
starvation of trophozoites,123 in contrast to EhRab7 and
EhRabA. Iron and serum starvation is associated with
altered cytokinesis and increased detergent-resistant cells, but
whether EhRab11 contributes to these phenotypes is
unknown.123 A related isoform, EhRab11B, also exhibits a
vesicular distribution, and overexpression of EhRab11B
in trophozoites leads to an increase in both intracellular
and secreted cysteine proteases.124 Amebae overexpressing
EhRab11B exhibit slightly increased exocytosis of a fluid-
phase marker and more efficiently kill mammalian cells, an
effect reversed by treatment with the cysteine protease
inhibitor E64.124 These findings suggest that the E. histolytica
Rab11 isoforms have non-redundant functions.
No studies of Rab GTPase nucleotide cycle regulators in
E. histolytica have yet emerged. The E. histolytica genome
encodes for B20 proteins with DENN (after ‘differentially
expressed in neoplastic vs normal’ cells) domains,68 known in
mammals to serve as Rab GEFs, along with other structurally
unrelated proteins.125 Also present are B50 Rab-GAP/TBC
(Tre-2, Bub2, and Cdc16) domain-containing proteins and
two putative Rab GDIs.68 Examination of these likely Rab
regulators may shed further light on signaling mechanisms
contributing to E. histolytica pathogenicity, especially in the
context of vesicular trafficking mechanics.
CONCLUSION AND PERSPECTIVE
A number of G proteins have been implicated in key
pathogenic processes of E. histolytica, particularly heterotri-
meric G proteins, a number of cytoskeleton-associated Rho
GTPases, and also Rab GTPases primarily involved in vesicular
trafficking. Exploitation of known signaling pathways
for pharmacological manipulation is attractive, both in the
development of tools for interrogating the specific functions of
G protein signaling in E. histolytica and as a potential approach
to the development of anti-amebiasis therapeutics. A first step
has been taken in developing small molecule inhibitors for
EhGEF1,100 and other E. histolytica RhoGEFs may be targetable
given some previous success in inhibiting mammalian Rho
GTPase activation (for example, Shutes et al.126 and Evelyn
et al.127). Some Ras and Rho GTPase effectors, particularly
kinases like the PAKs and members of the mitogen-activated
protein kinase cascade, have also proven tractable as
pharmacological targets in humans (for example, Rusconi
et al.128 and Zhao and Manser129). However, the importance
of Ras effectors and downstream kinases in E. histolytica
pathogenesis has not yet been explored. Particularly
promising for pharmacological development is the recently
described heterotrimeric G protein signaling within
E. histolytica,36,61 although identification of a bona fide
GPCR and ligand pair in E. histolytica remains a barrier at
this time.
Aside from pharmacological goals, much remains to be
discovered regarding the modulation of Ras superfamily
GTPase functions in E. histolytica, particularly regarding
nucleotide cycle regulators (GAPs, GEFs and GDIs). Also
unclear is the interplay among the well-populated small G
protein families in E. histolytica, such as the 420-member Rho
family and the 91-member Rab family. Are many of these
GTPases redundant in function and regulation? How is
GTPase specificity for effectors and nucleotide cycle regulators
achieved, given such large numbers of simultaneously
expressed G proteins in a single cell? Further study of both
heterotrimeric and small G proteins in E. histolytica will likely
add to our understanding of parasite biology and pathogeni-
city, as well as signaling in other organisms.
G protein in E. histolytica pathogenesis
DE Bosch and DP Siderovski
9
Experimental & Molecular Medicine
1 Ravdin JI. Amoebiasis. Imperial College Press: London, 2000.
2 WHO. WHO/PAHO/UNESCO report. A consultation with experts on
amoebiasis. Mexico City, Mexico 28–29 January, 1997. Epidemiol Bull
1997; 18: 13–14.
3 Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr. Amebiasis.
N Engl J Med 2003; 348: 1565–1573.
4 Korpe PS, Stott BR, Nazib F, Kabir M, Haque R, Herbein JF et al.
Evaluation of a rapid point-of-care fecal antigen detection test for
Entamoeba histolytica. Am J Trop Med Hyg 2012; 86: 980–981.
5 Haque R, Kabir M, Noor Z, Rahman SM, Mondal D, Alam F et al.
Diagnosis of amebic liver abscess and amebic colitis by detection of
Entamoeba histolytica DNA in blood, urine, and saliva by a real-time PCR
assay. J Clin Microbiol 2010; 48: 2798–2801.
6 Haque R, Mondal D, Duggal P, Kabir M, Roy S, Farr BM et al. Entamoeba
histolytica infection in children and protection from subsequent
amebiasis. Infect Immun 2006; 74: 904–909.
7 Anuar TS, Al-Mekhlafi HM, Abdul Ghani MK, Abu Bakar E, Azreen SN,
Salleh FM et al. Molecular epidemiology of amoebiasis in Malaysia:
highlighting the different risk factors of Entamoeba histolytica
and Entamoeba dispar infections among Orang Asli communities. Int J
Parasitol 2012; 42: 1165–1175.
8 Ramos F, Moran P, Gonzalez E, Garcia G, Ramiro M, Gomez A et al. High
prevalence rate of Entamoeba histolytica asymptomatic infection in a
rural Mexican community. Am J Trop Med Hyg 2005; 73: 87–91.
9 Yang B, Chen Y, Wu L, Xu L, Tachibana H, Cheng X. Seroprevalence of
Entamoeba histolytica infection in China. Am J Trop Med Hyg 2012; 87:
97–103.
10 Verkerke HP, Petri WA Jr, Marie CS. The dynamic interdependence of
amebiasis, innate immunity, and undernutrition. Semin Immunopathol
2012; 34: 771–785.
11 Hung CC, Chang SY, Ji DD. Entamoeba histolytica infection in men who
have sex with men. Lancet Infect Dis 2012; 12: 729–736.
12 Nozaki T, Kobayashi S, Takeuchi T, Haghighi A. Diversity of clinical
isolates of Entamoeba histolytica in Japan. Arch Med Res 2006; 37:
277–279.
13 Barwick RS, Uzicanin A, Lareau S, Malakmadze N, Imnadze P, Iosava M
et al. Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998.
Am J Trop Med Hyg 2002; 67: 623–631.
14 Christy NC, Petri WA Jr. Mechanisms of adherence, cytotoxicity
and phagocytosis modulate the pathogenesis of Entamoeba histolytica.
Future Microbiol 2011; 6: 1501–1519.
15 Aikat BK, Bhusnurmath SR, Pal AK, Chhuttani PN, Datta DV. The
pathology and pathogenesis of fatal hepatic amoebiasis—a study based
on 79 autopsy cases. Trans R Soc Trop Med Hyg 1979; 73: 188–192.
16 Knobloch J, Mannweiler E. Development and persistence of antibodies to
Entamoeba histolytica in patients with amebic liver abscess. Analysis of
216 cases. Am J Trop Med Hyg 1983; 32: 727–732.
17 Lofmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice
for treatment of anaerobic infections. Clin Infect Dis 2010; 50 (Suppl 1):
S16–S23.
18 Bansal D, Malla N, Mahajan RC. Drug resistance in amoebiasis. Indian J
Med Res 2006; 123: 115–118.
19 Debnath A, Parsonage D, Andrade RM, He C, Cobo ER, Hirata K et al.
A high-throughput drug screen for Entamoeba histolytica identifies a new
lead and target. Nat Med 2012; 18: 956–960.
20 Wani MY, Bhat AR, Azam A, Lee DH, Choi I, Athar F. Synthesis and
in vitro evaluation of novel tetrazole embedded 1,3,5-trisubstituted
pyrazoline derivatives as Entamoeba histolytica growth inhibitors.
Eur J Med Chem 2012; 54: 845–854.
21 Mushtaque M, Avecilla F, Azam A. Synthesis, characterization and
structure optimization of a series of thiazolidinone derivatives as
Entamoeba histolytica inhibitors. Eur J Med Chem 2012; 55: 439–448.
22 Abd Alla MD, Wolf R, White GL, Kosanke SD, Cary D, Verweij JJ et al.
Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba
histolytica infection and colitis in baboons (Papio sp.). Vaccine 2012;
30: 3068–3075.
23 Petri WA Jr, Haque R, Mann BJ. The bittersweet interface of parasite
and host: lectin-carbohydrate interactions during human invasion
by the parasite Entamoeba histolytica. Annu Rev Microbiol 2002; 56:
39–64.
24 Leippe M, Herbst R. Ancient weapons for attack and defense: the pore-
forming polypeptides of pathogenic enteric and free-living amoeboid
protozoa. J Eukaryot Microbiol 2004; 51: 516–521.
25 Que X, Reed SL. Cysteine proteinases and the pathogenesis of amebiasis.
Clin Microbiol Rev 2000; 13: 196–206.
26 Voigt H, Guillen N. New insights into the role of the cytoskeleton
in phagocytosis of Entamoeba histolytica. Cell Microbiol 1999; 1:
195–203.
27 Tavares P, Sansonetti P, Guillen N. The interplay between receptor
capping and cytoskeleton remodeling in Entamoeba histolytica. Arch
Med Res 2000; 31: S140–S142.
28 Meza I, Talamas-Rohana P, Vargas MA. The cytoskeleton of Entamoeba
histolytica: structure, function, and regulation by signaling pathways.
Arch Med Res 2006; 37: 234–243.
29 Labruyere E, Guillen N. Host tissue invasion by Entamoeba histolytica is
powered by motility and phagocytosis. Arch Med Res 2006; 37:
253–258.
30 Loftus B, Anderson I, Davies R, Alsmark UC, Samuelson J,
Amedeo P et al. The genome of the protist parasite Entamoeba
histolytica. Nature 2005; 433: 865–868.
31 Gilchrist CA, Houpt E, Trapaidze N, Fei Z, Crasta O, Asgharpour A et al.
Impact of intestinal colonization and invasion on the Entamoeba
histolytica transcriptome. Mol Biochem Parasitol 2006; 147:
163–176.
32 Anamika K, Bhattacharya A, Srinivasan N. Analysis of the protein kinome
of Entamoeba histolytica. Proteins 2008; 71: 995–1006.
33 Wennerberg K, Rossman KL, Der CJ. The Ras superfamily at a glance.
J Cell Sci 2005; 118: 843–846.
34 Oldham WM, Hamm HE. Heterotrimeric G protein activation by
G-protein-coupled receptors. Nat Rev Mol Cell Biol 2008; 9: 60–71.
35 Wennerberg K, Der CJ. Rho-family GTPases: it’s not only Rac and Rho
(and I like it). J Cell Sci 2004; 117: 1301–1312.
36 Gilchrist A. Modulating G-protein-coupled receptors: from traditional
pharmacology to allosterics. Trends Pharmacol Sci 2007; 28:
431–437.
37 Rask-Andersen M, Almen MS, Schioth HB. Trends in the exploitation of
novel drug targets. Nat Rev Drug Discov 2011; 10: 579–590.
38 Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS et al.
Crystal structure of the beta2 adrenergic receptor-Gs protein complex.
Nature 2011; 477: 549–555.
39 Coleman DE, Berghuis AM, Lee E, Linder ME, Gilman AG, Sprang SR.
Structures of active conformations of Gi alpha 1 and the mechanism of
GTP hydrolysis. Science 1994; 265: 1405–1412.
40 Aittaleb M, Boguth CA, Tesmer JJ. Structure and function of hetero-
trimeric G protein-regulated Rho guanine nucleotide exchange factors.
Mol Pharmacol 2010; 77: 111–125.
41 Kimple AJ, Bosch DE, Giguere PM, Siderovski DP. Regulators of G-protein
signaling and their Galpha substrates: promises and challenges in their
use as drug discovery targets. Pharmacol Rev 2011; 63: 728–749.
42 Tesmer JJ, Berman DM, Gilman AG, Sprang SR. Structure of RGS4
bound to AlF4–activated G(i alpha1): stabilization of the transition state
for GTP hydrolysis. Cell 1997; 89: 251–261.
43 Waldo GL, Ricks TK, Hicks SN, Cheever ML, Kawano T, Tsuboi K et al.
Kinetic scaffolding mediated by a phospholipase C-beta and Gq signaling
complex. Science 2010; 330: 974–980.
44 Kimple RJ, Kimple ME, Betts L, Sondek J, Siderovski DP. Structural
determinants for GoLoco-induced inhibition of nucleotide release by
Galpha subunits. Nature 2002; 416: 878–881.
45 Worthylake DK, Rossman KL, Sondek J. Crystal structure of Rac1 in
complex with the guanine nucleotide exchange region of Tiam1. Nature
2000; 408: 682–688.
46 Scheffzek K, Ahmadian MR, Kabsch W, Wiesmuller L, Lautwein A, Schmitz
F et al. The Ras-RasGAP complex: structural basis for GTPase activation
and its loss in oncogenic Ras mutants. Science 1997; 277: 333–338.
47 Gavriljuk K, Gazdag EM, Itzen A, Kotting C, Goody RS, Gerwert K.
Catalytic mechanism of a mammalian Rab{middle dot}RabGAP complex
in atomic detail. Proc Natl Acad Sci USA 2012; 109: 21348–21353.
48 Garcia-Mata R, Boulter E, Burridge K. The ‘invisible hand’: regulation
of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 2011; 12:
493–504.
49 Scheffzek K, Stephan I, Jensen ON, Illenberger D, Gierschik P. The Rac-
RhoGDI complex and the structural basis for the regulation of Rho
proteins by RhoGDI. Nat Struct Biol 2000; 7: 122–126.
50 Khan MA, Sen PC. Demonstration of histamine receptors on the surface
of Entamoeba histolytica. Indian J Exp Biol 1989; 27: 96–97.
51 Khan MA, Sen PC. Effect of histamine and serotonin on phagocytic
activity of Entamoeba histolytica. Indian J Exp Biol 1988; 26: 730–731.
G protein in E. histolytica pathogenesis
DE Bosch and DP Siderovski
10
Experimental & Molecular Medicine
52 Khan MA, Sen PC. Modulation of pathogenicity of Entamoeba histolytica
by histamine. Indian J Med Res 1988; 88: 225–227.
53 Khan MA, Sen PC, Mishra B. Enhancement of virulence of Entamoeba
histolytica by histamine in vitro. Indian J Exp Biol 1990; 28: 376–377.
54 Rios A, Hernandez-Ramirez VI, Moguel M, Bahena AIZ, Rosales-Encina
JL, Vargas MA et al. Participation of Rho, ROCK-2, and GAP activities
during actin microfilament rearrangements in Entamoeba histolytica
induced by fibronectin signaling. Cell Biol Int 2008; 32: 984–1000.
55 Manning-Cela R, Pina A, Meza I. cAMP levels and up-regulation of actin
mRNA in Entamoeba histolytica. Arch Med Res 1997; 28 (Spec No):
134–135.
56 Carbajal ME, Manning-Cela R, Pina A, Franco E, Meza I. Fibronectin-
induced intracellular calcium rise in Entamoeba histolytica trophozoites:
effect on adhesion and the actin cytoskeleton. Exp Parasitol 1996; 82:
11–20.
57 Siderovski DP, Kimple AJ, Willard FS. Large G-proteins. In: Begley TP
(ed.). Wiley Encyclopedia of Chemical Biology. John Wiley & Sons, Inc.,
2008, pp 1–9.
58 Soid-Raggi LG, Torres-Marquez ME, Meza I. Entamoeba histolytica:
identification of functional Gs and Gi proteins as possible signal
transduction elements in the interaction of trophozoites with fibronectin.
Exp Parasitol 1998; 90: 262–269.
59 Coppi A, Merali S, Eichinger D. The enteric parasite Entamoeba uses an
autocrine catecholamine system during differentiation into the infectious
cyst stage. J Biol Chem 2002; 277: 8083–8090.
60 Frederick J, Eichinger D. Entamoeba invadens contains the components
of a classical adrenergic signaling system. Mol Biochem Parasitol 2004;
137: 339–343.
61 Bosch DE, Kimple AJ, Muller RE, Giguere PM, Machius M, Willard FS et al.
Heterotrimeric G-protein signaling is critical to pathogenic processes in
Entamoeba histolytica. PLoS Pathog 2012; 8: e1003040.
62 Anantharaman V, Abhiman S, de Souza RF, Aravind L. Comparative
genomics uncovers novel structural and functional features of the
heterotrimeric GTPase signaling system. Gene 2011; 475: 63–78.
63 Bosch DE, Kimple AJ, Manning AJ, Muller RE, Willard FS, Machius M et al.
Structural determinants of RGS-RhoGEF signaling critical to Entamoeba
histolytica pathogenesis. Structure 2013; 21: 65–75.
64 Garcia-Marcos M, Ghosh P, Farquhar MG. GIV is a nonreceptor GEF for G
alpha i with a unique motif that regulates Akt signaling. Proc Natl Acad
Sci USA 2009; 106: 3178–3183.
65 Wittinghofer A, Vetter IR. Structure–function relationships of the G domain,
a canonical switch motif. Annu Rev Biochem 2011; 80: 943–971.
66 Johnston CA, Willard MD, Kimple AJ, Siderovski DP, Willard FS. A sweet
cycle for Arabidopsis G-proteins: recent discoveries and controversies
in plant G-protein signal transduction. Plant Signal Behav 2008; 3:
1067–1076.
67 Slessareva JE, Dohlman HG. G protein signaling in yeast: new components,
new connections, new compartments. Science 2006; 314: 1412–1413.
68 Aurrecoechea C, Barreto A, Brestelli J, Brunk BP, Caler EV, Fischer S et al.
AmoebaDB and MicrosporidiaDB: functional genomic resources for
Amoebozoa and Microsporidia species. Nucleic Acids Res 2011; 39:
D612–D619.
69 Shen PS, Lohia A, Samuelson J. Molecular cloning of ras and rap
genes from Entamoeba histolytica. Mol Biochem Parasitol 1994; 64:
111–120.
70 Kumagai M, Makioka A, Takeuchi T, Nozaki T. Molecular cloning and
characterization of a protein farnesyltransferase from the enteric
protozoan parasite Entamoeba histolytica. J Biol Chem 2004; 279:
2316–2323.
71 Lohia A, Samuelson J. Molecular cloning of a rho family gene of
Entamoeba histolytica. Mol Biochem Parasitol 1993; 58: 177–180.
72 Lohia A, Samuelson J. Heterogeneity of Entamoeba histolytica rac genes
encoding p21rac homologues. Gene 1996; 173: 205–208.
73 Bosch DE, Wittchen ES, Qiu C, Burridge K, Siderovski DP. Unique
structural and nucleotide exchange features of the Rho1 GTPase of
Entamoeba histolytica. J Biol Chem 2011; 286: 39236–39246.
74 Nakada-Tsukui K, Saito-Nakano Y, Husain A, Nozaki T. Conservation and
function of Rab small GTPases in Entamoeba: annotation of E. invadens
Rab and its use for the understanding of Entamoeba biology. Exp
Parasitol 2010; 126: 337–347.
75 Shen PS, Sanford JC, Samuelson J. Entamoeba histolytica: isoprenylation
of p21ras and p21rap in vitro. Exp Parasitol 1996; 82: 65–68.
76 Baines AT, Xu D, Der CJ. Inhibition of Ras for cancer treatment: the
search continues. Future Med Chem 2011; 3: 1787–1808.
77 Marion S, Laurent C, Guillen N. Signalization and cytoskeleton activity
through myosin IB during the early steps of phagocytosis in Entamoeba
histolytica: a proteomic approach. Cell Microbiol 2005; 7: 1504–1518.
78 Maugis B, Brugues J, Nassoy P, Guillen N, Sens P, Amblard F. Dynamic
instability of the intracellular pressure drives bleb-based motility. J Cell
Sci 2010; 123: 3884–3892.
79 Meza I. Extracellular matrix-induced signaling in Entamoeba histolytica:
its role in invasiveness. Parasitol Today 2000; 16: 23–28.
80 Zaki M, Andrew N, Insall RH. Entamoeba histolytica cell movement: a
central role for self-generated chemokines and chemorepellents.
Proc Natl Acad Sci USA 2006; 103: 18751–18756.
81 Godbold GD, Mann BJ. Cell killing by the human parasite Entamoeba
histolytica is inhibited by the Rho-inactivating C3 exoenzyme.
Mol Biochem Parasitol 2000; 108: 147–151.
82 Godbold GD, Corbett KD, Mann BJA. Rho-like small GTPase of
Entamoeba histolytica contains an unusual amino acid residue in a
conserved GDP-stabilization region and is not a substrate for C3
exoenzyme. Exp Parasitol 2002; 101: 107–110.
83 Majumder S, Schmidt G, Lohia A, Aktories K. EhRho1, a RhoA-like
GTPase of Entamoeba histolytica, is modified by clostridial glucosylating
cytotoxins. Appl Environ Microbiol 2006; 72: 7842–7848.
84 Bosch DE, Yang B, Siderovski DP. Entamoeba histolytica Rho1 regulates
actin polymerization through a divergent, diaphanous-related formin.
Biochemistry 2012; 51: 8791–8801.
85 Chesarone MA, DuPage AG, Goode BL. Unleashing formins to remodel
the actin and microtubule cytoskeletons. Nat Rev Mol Cell Biol 2010;
11: 62–74.
86 Ganguly A, Lohia A. The diaphanous protein from Entamoeba histolytica
controls cell motility and cytokinesis. Arch Med Res 2000; 31: S137–S139.
87 Majumder S, Lohia A. Entamoeba histolytica encodes unique formins, a
subset of which regulates DNA content and cell division. Infect Immun
2008; 76: 2368–2378.
88 Franco-Barraza J, Zamudio-Meza H, Franco E, MdC Dominguez-Robles,
Villegas-Sepulveda N, Meza I. Rho sgnaling in Entamoeba histolytica
modulates actomyosin-dependent activities stimulated during invasive
behavior. Cell Motil Cytoskeleton 2006: 117–131.
89 Ghosh SK, Samuelson J. Involvement of p21racA, phosphoinositide
3-kinase, and vacuolar ATPase in phagocytosis of bacteria and erythro-
cytes by Entamoeba histolytica: suggestive evidence for coincidental
evolution of amebic invasiveness. Infect Immun 1997; 65: 4243–4249.
90 Arias-Romero LE, de Jesus Almaraz-Barrera M, Diaz-Valencia JD,
Rojo-Dominguez A, Hernandez-Rivas R, Vargas M. EhPAK2, a novel
p21-activated kinase, is required for collagen invasion and capping in
Entamoeba histolytica. Mol Biochem Parasitol 2006; 149: 17–26.
91 Kumar A, Molli PR, Pakala SB, Bui Nguyen TM, Rayala SK, Kumar R.
PAK thread from amoeba to mammals. J Cell Biochem 2009; 107:
579–585.
92 Guillen N, Boquet P, Sansonetti P. The small GTP-binding protein
RacG regulates uroid formation in the protozoan parasite Entamoeba
histolytica. J Cell Sci 1998; 111(Pt 12): 1729–1739.
93 Campos-Parra AD, Hernandez-Cuevas NA, Hernandez-Rivas R, Vargas M.
EhNCABP166: a nucleocytoplasmic actin-binding protein from Enta-
moeba histolytica. Mol Biochem Parasitol 2010; 172: 19–30.
94 Labruyere E, Galy V, Sansonetti P, Guillen N. Distribution of a potential
p21-activated serine/threonine kinase (PAK) in Entamoeba histolytica.
Arch Med Res 2000; 31: S128–S130.
95 Labruyere E, Zimmer C, Galy V, Olivo-Marin J-C, Guillen N. EhPAK, a
member of the p21-activated kinase family, is involved in the control of
Entamoeba histolytica migration and phagocytosis. J Cell Sci 2003; 116:
61–71.
96 Dutta S, Sardar A, Ray D, Raha S. Molecular and functional character-
ization of EhPAK3, a p21 activated kinase from Entamoeba histolytica.
Gene 2007; 402: 57–67.
97 Santiago-Resendiz M, Vargas-Mejia M. The tail domain of Entamoeba
histolytica GEF: a guanine nucleotide exchange factor. Arch Med Res
2000; 31: S301–S302.
98 Aguilar-Rojas A, Almaraz-Barrera Mde J, Krzeminski M, Robles-Flores M,
Hernandez-Rivas R, Guillen N et al. Entamoeba histolytica: inhibition of
cellular functions by overexpression of EhGEF1, a novel Rho/Rac guanine
nucleotide exchange factor. Exp Parasitol 2005; 109: 150–162.
99 Hernandez-Cuevas NA, Campos-Parra AD, Almaraz-Barrera MdJ, Aguilar-
Rojas A, Rosa CHG-dl, Sosa-Peinado A et al. Entamoeba histolytica
EhGEF1 structure and mutational analysis: new specific residues critical
for function. Mol Biochem Parasitol 2009; 164: 118–125.
G protein in E. histolytica pathogenesis
DE Bosch and DP Siderovski
11
Experimental & Molecular Medicine
100 Hernandez-Cuevas NA, Hernandez-Rivas R, Sosa-Peinado A,
Rojo-Dominguez A, Vargas M. Identification and evaluation of inhibitors
of the EhGEF1 protein from Entamoeba histolytica. J Mol Recognit
2011; 24: 935–944.
101 Gonzalez De la Rosa CH, Arias-Romero LE, de Jesus Almaraz-Barrera M,
Hernandez-Rivas R, Sosa-Peinado A, Rojo-Dominguez A et al. EhGEF2, a
Dbl-RhoGEF from Entamoeba histolytica has atypical biochemical prop-
erties and participates in essential cellular processes. Mol Biochem
Parasitol 2007; 151: 70–80.
102 Arias-Romero LE, Rosa CHGdl, Almaraz-Barrera MdJ, Diaz-Valencia JD,
Sosa-Peinado A, Vargas M. EhGEF3, a novel Dbl family member,
regulates EhRacA activation during chemotaxis and capping in Enta-
moeba histolytica. Cell Motil Cytoskeleton 2007; 64: 390–404.
103 Powell RR, Welter BH, Hwu R, Bowersox B, Attaway C, Temesvari LA.
Entamoeba histolytica: FYVE-finger domains, phosphatidylinositol 3-
phosphate biosensors, associate with phagosomes but not fluid filled
endosomes. Exp Parasitol 2006; 112: 221–231.
104 Nakada-Tsukui K, Okada H, Mitra BN, Nozaki T. Phosphatidylinositol-
phosphates mediate cytoskeletal reorganization during phagocytosis via a
unique modular protein consisting of RhoGEF/DH and FYVE domains in
the parasitic protozoon Entamoeba histolytica. Cell Microbiol 2009; 11:
1471–1491.
105 Saito-Nakano Y, Nakazawa M, Shigeta Y, Takeuchi T, Nozaki T. Identifica-
tion and characterization of genes encoding novel Rab proteins from
Entamoeba histolytica. Mol Biochem Parasitol 2001; 116: 219–222.
106 Saito-Nakano Y, Loftus BJ, Hall N, Nozaki T. The diversity
of Rab GTPases in Entamoeba histolytica. Exp Parasitol 2005; 110:
244–252.
107 Temesvari LA, Harris EN, Stanley SL Jr, Cardelli JA. Early and late
endosomal compartments of Entamoeba histolytica are enriched in
cysteine proteases, acid phosphatase and several Ras-related Rab
GTPases. Mol Biochem Parasitol 1999; 103: 225–241.
108 Welter BH, Temesvari LA. A unique Rab GTPase, EhRabA, of Entamoeba
histolytica, localizes to the leading edge of motile cells. Mol Biochem
Parasitol 2004; 135: 185–195.
109 Welter BH, Powell RR, Leo M, Smith CM, Temesvari LA. A unique Rab
GTPase, EhRabA, is involved in motility and polarization of Entamoeba
histolytica cells. Mol Biochem Parasitol 2005; 140: 161–173.
110 Welter BH, Temesvari LA. Overexpression of a mutant form of EhRabA, a
unique Rab GTPase of Entamoeba histolytica, alters endoplasmic
reticulum morphology and localization of the Gal/GalNAc adherence
lectin. Eukaryot Cell 2009; 8: 1014–1026.
111 Rodriguez MA, Garcia-Perez RM, Garcia-Rivera G, Lopez-Reyes I,
Mendoza L, Ortiz-Navarrete V et al. An Entamoeba histolytica rab-like
encoding gene and protein: function and cellular location. Mol Biochem
Parasitol 2000; 108: 199–206.
112 Rodriguez MA, Orozco E. Characterization of the EhRabB recombinant
protein of Entamoeba histolytica. Arch Med Res 2000; 31: S171–S172.
113 Guzman-Medrano R, Castillo-Juarez BA, Garcia-Perez RM, Salas-Casas
A, Orozco E, Rodriguez MA. Entamoeba histolytica: alterations in
EhRabB protein in a phagocytosis deficient mutant correlate with the
Entamoeba dispar RabB sequence. Exp Parasitol 2005; 110: 259–264.
114 Marion S, Guillen N. Genomic and proteomic approaches highlight
phagocytosis of living and apoptotic human cells by the parasite
Entamoeba histolytica. Int J Parasitol 2006; 36: 131–139.
115 Juarez-Hernandez LJ, Garcia-Perez RM, Salas-Casas A, Garcia-Rivera G,
Orozco E, Rodriguez MA. Entamoeba histolytica: the over expression of a
mutated EhRabB protein produces a decrease of in vitro and in vivo
virulence. Exp Parasitol 2012; 133: 339–345.
116 Picazarri K, Luna-Arias JP, Carrillo E, Orozco E, Rodriguez MA. Enta-
moeba histolytica: identification of EhGPCR-1, a novel putative G
protein-coupled receptor that binds to EhRabB. Exp Parasitol 2005;
110: 253–258.
117 Welter BH, Laughlin RC, Temesvari LA. Characterization of a Rab7-like
GTPase, EhRab7: a marker for the early stages of endocytosis
in Entamoeba histolytica. Mol Biochem Parasitol 2002; 121:
254–264.
118 Saito-Nakano Y, Yasuda T, Shigeta Y, Nakazawa M, Takeuchi T, Nozaki T.
Identification and characterizaton of a Rab5 homologue in Entamoeba
histolytica. Arch Med Res 2000; 31: S155–S156.
119 Saito-Nakano Y, Yasuda T, Nakada-Tsukui K, Leippe M, Nozaki T. Rab5-
associated vacuoles play a unique role in phagocytosis of the enteric
protozoan parasite Entamoeba histolytica. J Biol Chem 2004; 279:
49497–49507.
120 Nakada-Tsukui K, Saito-Nakano Y, Ali V, Nozaki T. A retromerlike complex
is a novel Rab7 effector that is involved in the transport of the virulence
factor cysteine protease in the enteric protozoan parasite Entamoeba
histolytica. Mol Biol Cell 2005; 16: 5294–5303.
121 Juarez P, Sanchez-Lopez R, Ramos MA, Stock RP, Alagon A. Rab8 as a
molecular model of vesicular trafficking to investigate the latter steps of
the secretory pathway in Entamoeba histolytica. Arch Med Res 2000; 31:
S157–S159.
122 Juarez P, Sanchez-Lopez R, Stock RP, Olvera A, Ramos MA, Alagon A.
Characterization of the Ehrab8 gene, a marker of the late stages of the
secretory pathway of Entamoeba histolytica. Mol Biochem Parasitol
2001; 116: 223–228.
123 McGugan GC Jr, Temesvari LA. Characterization of a Rab11-like GTPase,
EhRab11, of Entamoeba histolytica. Mol Biochem Parasitol 2003; 129:
137–146.
124 Mitra BN, Saito-Nakano Y, Nakada-Tsukui K, Sato D, Nozaki T. Rab11B
small GTPase regulates secretion of cysteine proteases in the
enteric protozoan parasite Entamoeba histolytica. Cell Microbiol 2007;
9: 2112–2125.
125 Barr F, Lambright DG. Rab GEFs and GAPs. Curr Opin Cell Biol 2010;
22: 461–470.
126 Shutes A, Onesto C, Picard V, Leblond B, Schweighoffer F, Der CJ.
Specificity and mechanism of action of EHT 1864, a novel small
molecule inhibitor of Rac family small GTPases. J Biol Chem 2007;
282: 35666–35678.
127 Evelyn CR, Ferng T, Rojas RJ, Larsen MJ, Sondek J, Neubig RR. High-
throughput screening for small-molecule inhibitors of LARG-stimulated
RhoA nucleotide binding via a novel fluorescence polarization assay.
J Biomol Screen 2009; 14: 161–172.
128 Rusconi P, Caiola E, Broggini M. RAS/RAF/MEK inhibitors in oncology.
Curr Med Chem 2012; 19: 1164–1176.
129 Zhao ZS, Manser E. Do PAKs make good drug targets? F1000 Biol Rep
2010; 2: 70.
This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivs 3.0 Un-
ported License. To view a copy of this license, visit http://
creativecommons.org/licenses/by-nc-nd/3.0/
G protein in E. histolytica pathogenesis
DE Bosch and DP Siderovski
12
Experimental & Molecular Medicine
